24
Participants
Start Date
May 31, 2011
Primary Completion Date
July 31, 2011
Study Completion Date
July 31, 2011
Rifampicin treatment
induction of CYP3A4 with one of three rifampicin doses (10, 20, 100 mg QD)
Clinical Pharmacology Trial Unit (CPTU), Karolinska University Hospital, Stockholm
Collaborators (1)
AstraZeneca
INDUSTRY
Karolinska University Hospital
OTHER